The development of treatments for liver fibrosis and other fatty liver diseases is predicted to be the focus of increased research by several private research organisations, which is anticipated to fuel Liver Fibrosis Treatment Market expansion. For instance, the Department of Pharmacology at the University of Virginia and the College of Science at Virginia Tech, both located in the United States, received a US$ 400,000 grant from the Virginia Biosciences Health Research Corporation (VBHRC) in August 2018 along with US$ 800,000 in matching funds from Continuum Biosciences, Inc. With this award and matching money, researchers will be able to create medications to treat nonalcoholic steatohepatitis (NASH).
Read More:
https://bloggerstrive.blogspot.com/2023/03/liver-fibrosis-treatment-market-size.html
